Follow the Story
‘Pharma Bro’ Martin Shkreli welcomes newborn son to the world with this bizarre name
Supreme Court rejects ‘Pharma Bro’ Martin Shkreli’s appeal of $65M in penalties
Writer who ditched husband, job for ‘Pharma Bro’ Martin Shkreli defends Olivia Nuzzi over alleged RFK Jr. affair: ‘So f-ing tired’
‘Pharma Bro’ Martin Shkreli ordered to give up one-of-a-kind Wu-Tang Clan album he paid $2M for
‘Pharma Bro’ Martin Shkreli claims he and Barron Trump created DJT crypto token
‘Pharma Bro’ Martin Shkreli allegedly copied one-of-a-kind Wu-Tang Clan album that sold for $4.75M
Nearly 16 hours in, and jurors have yet to return a verdict in the federal case of notorious “pharma bro” Martin Shkreli.
The panel deliberated just over eight hours Tuesday before calling it quits. They sent out their first note mid-afternoon, asking Brooklyn federal Judge Kiyo Matsumoto three questions regarding “assets under management” and “fraudulent intent.”
“Do assets under management refer to a particular fund being discussed or all assets managed by the PM/general partner?” the question read, according to Matsumoto.
Jurors also asked for the legal definition of “assets under management” and that the judge “expand or elaborate your definition of fraudulent intent.”
“There’s no legal definition of ‘assets under management’ in the record,” Matsumoto told the beleaguered group. “This is an issue that is up to you, the jury, to resolve.”
Matsumoto also reminded the panel that “fraudulent intent” is differently defined under separate counts in the inducement, and asked them to refer to the legal document.
The tired-looking group will return Wednesday at 9:00a.m. to continue deliberations.
Shkreli, 34, faces up to 20 years behind bars if convicted of various counts of conspiracy to commit securities and wire fraud.
